39.1: Appendix B- Major Fluid and Electrolyte Imbalances
- Page ID
- 111740
\( \newcommand{\vecs}[1]{\overset { \scriptstyle \rightharpoonup} {\mathbf{#1}} } \)
\( \newcommand{\vecd}[1]{\overset{-\!-\!\rightharpoonup}{\vphantom{a}\smash {#1}}} \)
\( \newcommand{\dsum}{\displaystyle\sum\limits} \)
\( \newcommand{\dint}{\displaystyle\int\limits} \)
\( \newcommand{\dlim}{\displaystyle\lim\limits} \)
\( \newcommand{\id}{\mathrm{id}}\) \( \newcommand{\Span}{\mathrm{span}}\)
( \newcommand{\kernel}{\mathrm{null}\,}\) \( \newcommand{\range}{\mathrm{range}\,}\)
\( \newcommand{\RealPart}{\mathrm{Re}}\) \( \newcommand{\ImaginaryPart}{\mathrm{Im}}\)
\( \newcommand{\Argument}{\mathrm{Arg}}\) \( \newcommand{\norm}[1]{\| #1 \|}\)
\( \newcommand{\inner}[2]{\langle #1, #2 \rangle}\)
\( \newcommand{\Span}{\mathrm{span}}\)
\( \newcommand{\id}{\mathrm{id}}\)
\( \newcommand{\Span}{\mathrm{span}}\)
\( \newcommand{\kernel}{\mathrm{null}\,}\)
\( \newcommand{\range}{\mathrm{range}\,}\)
\( \newcommand{\RealPart}{\mathrm{Re}}\)
\( \newcommand{\ImaginaryPart}{\mathrm{Im}}\)
\( \newcommand{\Argument}{\mathrm{Arg}}\)
\( \newcommand{\norm}[1]{\| #1 \|}\)
\( \newcommand{\inner}[2]{\langle #1, #2 \rangle}\)
\( \newcommand{\Span}{\mathrm{span}}\) \( \newcommand{\AA}{\unicode[.8,0]{x212B}}\)
\( \newcommand{\vectorA}[1]{\vec{#1}} % arrow\)
\( \newcommand{\vectorAt}[1]{\vec{\text{#1}}} % arrow\)
\( \newcommand{\vectorB}[1]{\overset { \scriptstyle \rightharpoonup} {\mathbf{#1}} } \)
\( \newcommand{\vectorC}[1]{\textbf{#1}} \)
\( \newcommand{\vectorD}[1]{\overrightarrow{#1}} \)
\( \newcommand{\vectorDt}[1]{\overrightarrow{\text{#1}}} \)
\( \newcommand{\vectE}[1]{\overset{-\!-\!\rightharpoonup}{\vphantom{a}\smash{\mathbf {#1}}}} \)
\( \newcommand{\vecs}[1]{\overset { \scriptstyle \rightharpoonup} {\mathbf{#1}} } \)
\(\newcommand{\longvect}{\overrightarrow}\)
\( \newcommand{\vecd}[1]{\overset{-\!-\!\rightharpoonup}{\vphantom{a}\smash {#1}}} \)
\(\newcommand{\ket}[1]{\left| #1 \right>}\)
\(\newcommand{\bra}[1]{\left< #1 \right|}\)
\(\newcommand{\braket}[2]{\left< #1 \vphantom{#2} \right| \left. #2 \vphantom{#1} \right>}\)
\(\newcommand{\braopket}[3]{\left< #1 \vphantom{#2}\vphantom{#3} \right| #2 \vphantom{#1}\vphantom{#3} \left| #3 \vphantom{#1}\vphantom{#2} \right>}\)
\(\newcommand{\qmvec}[1]{\mathbf{\vec{#1}}}\)
\(\newcommand{\op}[1]{\hat{\mathbf{#1}}}\)
\(\newcommand{\expect}[1]{\langle #1 \rangle}\)
\(\newcommand{\dfn}[1]{\emph{\textbf{#1}}}\)
Any condition that can cause fluid electrolyte imbalances, such as cardiac, circulatory, endocrine, gastrointestinal or lung disorders, malnutrition, kidney dysfunction, or acid-base imbalance requires frequent monitoring of blood electrolytes (Ambati et al., 2023). Electrolyte evaluation is done through a blood specimen using lithium heparin tubes. Common laboratory ranges will vary slightly depending on location and facility protocols. Table B1 lists common laboratory ranges and clinical manifestations for each electrolyte.
| Electrolyte | Normal Range | Mild to Moderate Range | Complications |
|---|---|---|---|
| Sodium | 135–145 mmol/L | Hyponatremia: 125–135 mmol/L Hypernatremia: 145–160 mmol/L |
May lead to neurological consequences such as seizures |
| Potassium | 3.6–5.5 mmol/L | Mild hypokalemia: < 3.6 mmol/L Moderate hypokalemia: < 2.5 mmol/L Mild hyperkalemia: 5–5.5 mmol/L Moderate hyperkalemia: 5.5–6.5 mmol/L |
May lead to cardiac arrhythmias, fatigue, lethargy, and muscle weakness |
| Calcium | 8.8–10.7 mg/dL | Hypocalcemia: < 8.8 mg/dL Hypercalcemia: > 10.7–11.5 mg/dL |
May lead to cardiac arrhythmias, fatigue, lethargy, and muscle weakness |
| Bicarbonate | 23–30 mmol/L | Acidosis: < 23 mmol/L Alkalosis: > 30 mmol/L Increases or decreases depending on acid-base status either respiratory or metabolic |
Acidosis: may inhibit O2 transport at the cellular level Alkalosis: may cause tetany and paresthesia |
| Magnesium | 1.46–2.68 mg/dL | Hypomagnesemia: < 1.46 mg/dL Hypermagnesemia: > 2.68 mg/dL |
May lead to neurological consequences such as seizures, imbalances, fatigue, lethargy, and muscle weakness |
| Chloride | 95–105 mEq/L | Hypochloremia: < 95 mEq/L Hyperchloremia: > 105 mEq/L |
Hypochloremia may lead to fatigue and weakness Hyperchloremia may lead to high blood pressure, changes in fluid secretion, headache, metabolic acidosis, muscle cramps, arrythmias, and confusion |
| Phosphorus | 3.4–4.5 mg/dL | Hypophosphatemia: < 2.5 mg/dL Hyperphosphatemia: > 4.5 mg/dL |
May lead to bone and muscle disorders and increase risk of cardiovascular and neurological disorders |
Significant variation can occur depending on the cause of each electrolyte imbalance. Many electrolytes are interdependent of one another, meaning that if one is abnormal, it can elicit a chain reaction causing others to become abnormal (Kraut & Madias, 2017). The delicate balance of fluid and electrolytes within the body to maintain homeostasis needs constant and comprehensive evaluation. Table B2 lists the most common causes.
| Electrolyte | Cause |
|---|---|
| Sodium | Hyponatremia: adrenal insufficiency, cirrhosis, chronic hyperglycemia, heart failure, low dietary sodium intake, polydipsia, severe dyslipidemia, and syndrome of inappropriate antidiuretic hormone secretion (SIADH) Hypernatremia: hypertonic IV administration, osmotic diuresis, or unreplaced fluid loss via the skin or gastrointestinal tract |
| Potassium | Hypokalemia: aldosteronism or administration of loop diuretics Hyperkalemia: acute kidney injury, administration of beta blockers, insulin deficiency, metabolic acidosis |
| Calcium | Hypercalcemia: malignancy, hyperparathyroidism, malignancies, or tuberculosis Hypocalcemia: pancreatitis, parathyroid dysfunction, hypomagnesemia, or sepsis |
| Bicarbonate | Increase: metabolic alkalosis or respiratory acidosis Decrease: metabolic acidosis or respiratory alkalosis |
| Magnesium | Hypermagnesemia: ingestion of high amounts of oral magnesium, such as over-the-counter antacids, and renal failure Hypomagnesemia: alcohol use disorder, diuretic administration, or fluid loss such as from excessive vomiting and diarrhea |
| Chloride | Hyperchloremia: administration of excessive IV NS, diarrhea, ingestion of saltwater, and excessive amounts of salt Hypochloremia: excessive vomiting, diarrhea, or other gastrointestinal fluid loss |
| Phosphorus | Hypophosphatemia: parathyroid disorders, and vitamin D deficiency Hyperphosphatemia: kidney injury and parathyroid disorders |
References
Ambati, R., Kho, L. K., Prentice, D., & Thompson, A. (2023). Osmotic demyelination syndrome: novel risk factors and proposed pathophysiology. Internal Medicine Journal, 53(7), 1154–1162. doi.org/10.1111/imj.15855
Kraut, J. A., & Madias, N. E. (2017). Adverse effects of the metabolic acidosis of chronic kidney disease. Advances in Chronic Kidney Disease, 24(5), 289–297. https://doi.org/10.1053/j.ackd.2017.06.005
Hoppe, L. K., Muhlack, D. C., Koenig, W., Carr, P. R., Brenner, H., & Schöttker, B. (2018). Association of abnormal serum potassium levels with arrhythmias and cardiovascular mortality: A systematic review and meta-analysis of observational studies. Cardiovascular Drugs and Therapy, 32(2), 197–212. https://doi.org/10.1007/s10557-018-6783-0
Shrimanker, I., & Bhattarai, S. Electrolytes. (2023 Jul 24). StatPearls [Internet]. www.ncbi.nlm.nih.gov/books/NBK541123/


